Anna Brand
Overview
Explore the profile of Anna Brand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muller M, Brand A, Mattig I, Spethmann S, Messroghli D, Hahn K, et al.
Circ Heart Fail
. 2025 Jan;
18(2):e012146.
PMID: 39866106
Background: Despite previous histopathologic evidence for its presence, the role of myocardial inflammation in the development and progression of cardiac transthyretin amyloidosis (ATTR-CA) remains insufficiently understood. Thus, this study sought...
2.
Muller M, Spethmann S, Messroghli D, Brand A, Mattig I, Hahn K, et al.
JACC Adv
. 2025 Jan;
4(2):101568.
PMID: 39826440
Background: Biomarker-based prognostic staging systems, including the National Amyloidosis Centre (NAC) and the Mayo staging systems, are widely-used but have only been validated for treatment-naive patients with cardiac transthyretin amyloidosis...
3.
Primessnig U, Wiedenhofer J, Trippel T, Loddenkemper C, Schrader H, Brand A, et al.
Front Cardiovasc Med
. 2024 Jul;
11:1400626.
PMID: 39077114
Introduction: There is a lack of real-world data directly comparing different valve prostheses for transaortic valve replacement (TAVR). We aimed to compare early clinical outcomes at 30-days between the self-expandable...
4.
Muller M, Latinova E, Brand A, Mattig I, Spethmann S, Messroghli D, et al.
J Am Heart Assoc
. 2024 Jul;
13(14):e033478.
PMID: 38958150
Background: Results from ATTR-ACT (Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy) indicate that tafamidis prolongs survival and reduces cardiovascular hospitalizations in cardiac transthyretin amyloidosis (ATTR-CA). However, real-world...
5.
Steudel T, Barzen G, Frumkin D, Romero-Dorta E, Spethmann S, Hindricks G, et al.
Eur Heart J Open
. 2024 Jun;
4(3):oeae041.
PMID: 38863522
Aims: Layer-specific left ventricular (LV) strain alterations have been suggested as a specific finding in Fabry disease (FD). Our study aimed to assess the diagnostic value of layer-specific radial strain...
6.
Pernice H, Knorz A, Wetzel P, Herrmann C, Muratovic H, Rieber F, et al.
Sci Rep
. 2024 May;
14(1):10111.
PMID: 38698025
In contrast to inherited transthyretin amyloidosis (A-ATTRv), neuropathy is not a classic leading symptom of wild type transthyretin amyloidosis (A-ATTRwt). However, neurological symptoms are increasingly relevant in A-ATTRwt as well....
7.
Thevathasan T, Gregers E, Mork S, Degbeon S, Linde L, Andreasen J, et al.
Resuscitation
. 2024 Feb;
198:110149.
PMID: 38403182
Aim: Extracorporeal cardiopulmonary resuscitation (ECPR) can be considered in selected patients with refractory cardiac arrest. Given the risk of patient futility and high resource utilisation, identifying ECPR candidates, who would...
8.
Mattig I, Steudel T, Klingel K, Barzen G, Frumkin D, Spethmann S, et al.
Sci Rep
. 2024 Jan;
14(1):2445.
PMID: 38291191
Echocardiographic differentiation of cardiac amyloidosis (CA) and Fabry disease (FD) is often challenging using standard echocardiographic parameters. We retrospectively analyzed the diagnostic accuracy of right heart and left atrial strain...
9.
Kommoss K, Bieler T, Ringen J, Lehmann A, Mihalceanu S, Hobohm L, et al.
J Mol Med (Berl)
. 2023 Dec;
102(2):247-255.
PMID: 38127137
Objective parameters to quantify psoriatic inflammation are needed for interdisciplinary patient care, as well as preclinical experimental models. This study evaluates neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in psoriasis...
10.
Mattig I, Steudel T, Barzen G, Frumkin D, Spethmann S, Romero Dorta E, et al.
Int J Cardiol
. 2023 Dec;
397:131629.
PMID: 38048880
Background: Cardiac amyloidosis (CA) and Fabry disease (FD) cause myocardial damage but may also affect the valvular and subvalvular apparatus. We aimed to evaluate the diagnostic accuracy of new echocardiographic...